4//SEC Filing
Dutia Suren G 4
Accession 0001213900-24-109299
CIK 0001851484other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:07 PM ET
Size
6.9 KB
Accession
0001213900-24-109299
Insider Transaction Report
Form 4
Dutia Suren G
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+125,000→ 125,000 totalExercise: $1.07Exp: 2034-12-12→ Common Stock (125,000 underlying)
Holdings
- 150,000
Stock Option (Right to Buy)
Exercise: $2.15Exp: 2033-07-05→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
- [F2]These options are 100% vested.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001514063
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:07 PM ET
- Size
- 6.9 KB